Parkinson Disease

9 protocols meet the specified criteria

OCR16660

Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System

OCR16797

Evaluation of the Personal KinetiGraph (PKG ) to Improve Insight into Parkinson s Disease Status (APPRISE)

OCR16821

Mobile Decision Support System for Nurse Management of Neuromodulation Therapy

OCR16903

A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two-Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants with Parkinson s Disease (PD)

OCR17911

Effect of LY3154207 on Cognition in Mild to Moderate Parkinson s Disease Dementia (PDD) (The PRESENCE Study)

OCR18097

A Proof of Concept Study to Investigate the Effect of IPT803 Adjunct Treatment in Patients with Parkinson's Disease

OCR24502

A 14-week, Double-blind, Randomized, Three-arm, Parallel Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)

OCR27523

DUOdopa/Duopa in Patients With Advanced Parkinson's Disease (PD) - a GLobal Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE)

OCR28182

Implantable Neurostimulator for the Treatment of Parkinson's Disease